According to Applied DNA Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.363333. At the end of 2022 the company had a P/E ratio of -51.1.
Year | P/E ratio | Change |
---|---|---|
2022 | -51.1 | 23.25% |
2021 | -41.4 | 28.8% |
2020 | -32.2 | 175.31% |
2019 | -11.7 | -41.56% |
2018 | -20.0 | -71.7% |
2017 | -70.7 | 3.14% |
2016 | -68.5 | -64.05% |
2015 | -191 | 229.74% |
2014 | -57.8 | -62.48% |
2013 | -154 | -36.16% |
2012 | -241 | 602.06% |
2011 | -34.4 | -42.72% |
2010 | -60.0 | -200% |
2009 | 60.0 | -340% |
2008 | -25.0 | 37.5% |
2007 | -18.2 | -54.55% |
2006 | -40.0 | 209.51% |
2005 | -12.9 | -56.18% |
2004 | -29.5 | -70.92% |
2003 | -101 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
38.3 | -10,652.41% | ๐บ๐ธ USA | |
17.1 | -4,802.41% | ๐บ๐ธ USA | |
23.7 | -6,636.26% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.